A Trial Investigating the Pharmacodynamic Properties of NN1250 in Japanese Subjects With Type 2 Diabetes.

Trial Profile

A Trial Investigating the Pharmacodynamic Properties of NN1250 in Japanese Subjects With Type 2 Diabetes.

Discontinued
Phase of Trial: Phase I

Latest Information Update: 26 Nov 2013

At a glance

  • Drugs Insulin degludec (Primary)
  • Indications Type 2 diabetes mellitus
  • Focus Pharmacodynamics; Pharmacokinetics
  • Most Recent Events

    • 04 Jan 2012 Planned end date changed from 1 May 2012 to 1 Dec 2011 as reported by ClinicalTrials.gov.
    • 04 Jan 2012 Actual patients number (1) added as reported by ClinicalTrials.gov.
    • 04 Jan 2012 Status changed from recruiting to discontinued as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top